Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
about
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Co-clinical Analysis of a Gene ...... se to 5α-reductase Inhibition.
@en
type
label
Co-clinical Analysis of a Gene ...... se to 5α-reductase Inhibition.
@en
prefLabel
Co-clinical Analysis of a Gene ...... se to 5α-reductase Inhibition.
@en
P2093
P2860
P1433
P1476
Co-clinical Analysis of a Gene ...... nse to 5α-reductase Inhibition
@en
P2093
Antonina Mitrofanova
Cory Abate-Shen
David M Golombos
Elahe A Mostaghel
Jaime Yeji Kim
Juan Miguel Mosquera
Renu K Virk
Roseann Zott
Serge Cremers
P2860
P304
P356
10.1016/J.EURURO.2017.03.031
P407
P577
2017-04-04T00:00:00Z